NASDAQ:CBIO
$0.231
(
8.60%
)
Friday, 2nd Jun 2023
Catalyst Biosciences Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.210 | $0.240 | Friday, 2nd Jun 2023 CBIO stock ended at $0.231. This is 8.6% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 9.09% from a day low at $0.220 to a day high of $0.240. |
| 90 days | $0.189 | $0.259 | |
| 52 weeks | $0.189 | $2.09 |
Historical Catalyst Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $0.220 | $0.240 | $0.220 | $0.231 | 350 596 |
| 2023-06-01 | $0.240 | $0.240 | $0.210 | $0.213 | 302 780 |
| 2023-05-31 | $0.240 | $0.240 | $0.220 | $0.220 | 162 657 |
| 2023-05-30 | $0.230 | $0.235 | $0.226 | $0.231 | 331 534 |
| 2023-05-26 | $0.226 | $0.235 | $0.221 | $0.226 | 50 177 |
| 2023-05-25 | $0.240 | $0.240 | $0.220 | $0.220 | 115 344 |
| 2023-05-24 | $0.230 | $0.236 | $0.222 | $0.230 | 38 035 |
| 2023-05-23 | $0.240 | $0.240 | $0.222 | $0.230 | 425 287 |
| 2023-05-22 | $0.240 | $0.240 | $0.230 | $0.235 | 66 385 |
| 2023-05-19 | $0.236 | $0.236 | $0.230 | $0.232 | 57 190 |
| 2023-05-18 | $0.220 | $0.238 | $0.220 | $0.227 | 174 255 |
| 2023-05-17 | $0.230 | $0.238 | $0.230 | $0.230 | 65 733 |
| 2023-05-16 | $0.238 | $0.238 | $0.225 | $0.230 | 151 845 |
| 2023-05-15 | $0.221 | $0.230 | $0.220 | $0.220 | 97 238 |
| 2023-05-12 | $0.220 | $0.233 | $0.220 | $0.221 | 77 108 |
| 2023-05-11 | $0.220 | $0.239 | $0.220 | $0.226 | 363 965 |
| 2023-05-10 | $0.220 | $0.230 | $0.220 | $0.220 | 120 732 |
| 2023-05-09 | $0.220 | $0.234 | $0.210 | $0.211 | 209 256 |
| 2023-05-08 | $0.220 | $0.220 | $0.210 | $0.210 | 114 894 |
| 2023-05-05 | $0.210 | $0.220 | $0.210 | $0.211 | 23 538 |
| 2023-05-04 | $0.210 | $0.236 | $0.210 | $0.215 | 163 404 |
| 2023-05-03 | $0.210 | $0.220 | $0.210 | $0.211 | 134 825 |
| 2023-05-02 | $0.210 | $0.215 | $0.202 | $0.212 | 43 540 |
| 2023-05-01 | $0.220 | $0.220 | $0.200 | $0.201 | 133 927 |
| 2023-04-28 | $0.220 | $0.240 | $0.210 | $0.212 | 190 196 |
| 2023-04-27 | $0.230 | $0.232 | $0.220 | $0.226 | 116 005 |
| 2023-04-26 | $0.231 | $0.238 | $0.230 | $0.230 | 75 905 |
| 2023-04-25 | $0.240 | $0.242 | $0.233 | $0.233 | 179 206 |
| 2023-04-24 | $0.240 | $0.242 | $0.231 | $0.237 | 65 847 |
| 2023-04-21 | $0.230 | $0.247 | $0.230 | $0.240 | 211 913 |
| 2023-04-20 | $0.240 | $0.240 | $0.230 | $0.239 | 94 102 |
| 2023-04-19 | $0.230 | $0.238 | $0.227 | $0.237 | 162 904 |
| 2023-04-18 | $0.230 | $0.240 | $0.227 | $0.235 | 178 015 |
| 2023-04-17 | $0.219 | $0.245 | $0.210 | $0.230 | 1 176 990 |
| 2023-04-14 | $0.220 | $0.220 | $0.206 | $0.210 | 260 676 |
| 2023-04-13 | $0.220 | $0.222 | $0.206 | $0.220 | 192 322 |
| 2023-04-12 | $0.220 | $0.222 | $0.210 | $0.213 | 175 160 |
| 2023-04-11 | $0.210 | $0.220 | $0.206 | $0.214 | 162 671 |
| 2023-04-10 | $0.209 | $0.213 | $0.200 | $0.205 | 274 299 |
| 2023-04-06 | $0.210 | $0.215 | $0.200 | $0.209 | 160 828 |
| 2023-04-05 | $0.216 | $0.220 | $0.200 | $0.209 | 136 825 |
| 2023-04-04 | $0.220 | $0.220 | $0.210 | $0.211 | 99 212 |
| 2023-04-03 | $0.220 | $0.220 | $0.200 | $0.210 | 234 032 |
| 2023-03-31 | $0.208 | $0.210 | $0.200 | $0.207 | 305 186 |
| 2023-03-30 | $0.199 | $0.208 | $0.199 | $0.205 | 169 151 |
| 2023-03-29 | $0.200 | $0.200 | $0.190 | $0.199 | 96 645 |
| 2023-03-28 | $0.200 | $0.205 | $0.190 | $0.190 | 248 691 |
| 2023-03-27 | $0.200 | $0.206 | $0.193 | $0.200 | 301 106 |
| 2023-03-24 | $0.208 | $0.208 | $0.190 | $0.208 | 214 692 |
| 2023-03-23 | $0.200 | $0.215 | $0.200 | $0.201 | 633 010 |
About Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
